you are viewing a single comment's thread.
what about the NEXT offering, and the NEXT?
You will need 10 offerings of 10M each to get to DNDN's number of shares. I suspect we reach the final stage and FDA approval FAR PRIOR to that point. Funny how ignorant public always penalize a Co for ensuring its survival. Survival means that we will make it to the finish line.32 or 45 Million shares is TOTALLY irrelevant. Judging fr DNDN's story of 145 M shares, it is obvious that the final goal is to get to a marketable product.
Well, positive clinical results might be expected for having such an accumulated debt. No?
AJet, It is good to see a sane post this morning. I would have liked to see the offering at a bit higher price, but we all new an offering was coming because they said it was. A lot of short term thinking going on here today.
new to this board? hmmm.